It's a Wrap! Pharma-Bio Industry Set to Complete $4.6 Billion in North American Projects in First-Quarter 2018
It's a Wrap! Pharma-Bio Industry Set to Complete $4.6 Billion in North American Projects in First-Quarter 2018
Attachment: 1Q18 North American Pharma-Biotech Project Completions
SUGAR LAND--March 20, 2018--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)-- The Pharmaceutical-Biotech Industry is on track to complete construction on 383 North American capital and maintenance projects in the first quarter of 2018. A recent survey of reported projects in Industrial Info's Pharmaceutical-Biotech Online Platform reveals that the projects have a total investment value (TIV) of $4.6 billion.
Within this article: Details of major U.S. Pharma-Biotech project completions
Companies featured: Jacobs Engineering Group Incorporated (NYSE:JEC), Bristol-Myers Squibb Company (NYSE:BMY)
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- West Coast Surfs into Second-Quarter 2017 on $1.2 Billion Investment Wave o...
- BMS Investing $400 Million in Dublin Sterile Drug Expansion
- Solar Demand Drives U.S. Semiconductor & Computer Segment Growth
- U.S. Semiconductor, High-Tech Demand Drives $17 Billion in 4Q Kickoffs
- Jacobs Solutions Has Hand in $75 Billion Worth of U.S. Projects